References
Mocellin R, Walterfang M, Velakoulis D (2007) Hashimoto’s encephalopathy: epidemiology, pathogenesis and management. CNS Drugs 21:799–811
Canton A, de Fabregas O, Tintore M, Mesa J, Codina A, Simó R (2000) Encephalopathy associated to autoimmune thyroid disease: a more appropriate term for an underestimated condition? J Neurol Sci 176:65–69
Ferracci F, Moretto G, Candeago RM, Cimini N, Conte F, Gentile M, Papa N, Carnevale A (2003) Antithyroid antibodies in the CSF: their role in the pathogenesis of Hashimoto’s encephalopathy. Neurology 60:712–714
Blanchin S, Coffin C, Viader F, Ruf J, Carayon P, Potier F, Portier E, Comby E, Allouche S, Ollivier Y, Reznik Y, Ballet JJ (2007) Anti-thyroperoxidase antibodies from patients with Hashimoto’s encephalopathy bind to cerebellar astrocytes. J Neuroimmunol 192:13–20
Chaudhuri A, Behan PO (2003) The clinical spectrum, diagnosis, pathogenesis and treatment of Hashimoto’s encephalopathy (recurrent acute disseminated encephalomyelitis). Curr Med Chem 10:1945–1953
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Onesti, E., Koudriavtseva, T., Galiè, E. et al. A possible case of Hashimoto’s encephalopathy after surgery and radiometabolic therapy for thyroid carcinoma. Neurol Sci 34, 1489–1491 (2013). https://doi.org/10.1007/s10072-012-1234-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-012-1234-3